Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China
· Delayed Price · Currency is CNY 12.42
+0.18 (1.47%)
Mar 10, 2026, 3:04 PM CST
SHE:301211 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 5,187 | 6,123 | 6,264 | 8,316 | 9,026 | - | Upgrade
|
| Market Cap Growth | -4.31% | -2.25% | -24.68% | -7.87% | - | - | Upgrade
|
| Enterprise Value | 3,619 | 4,511 | 4,416 | 6,427 | 8,614 | - | Upgrade
|
| Last Close Price | 12.42 | 14.46 | 14.38 | 18.86 | 20.20 | - | Upgrade
|
| PE Ratio | 137.18 | 66.88 | 35.57 | 66.11 | 74.20 | - | Upgrade
|
| PS Ratio | 12.04 | 13.73 | 9.45 | 16.15 | 16.70 | - | Upgrade
|
| PB Ratio | 2.30 | 2.65 | 2.66 | 3.65 | 4.06 | - | Upgrade
|
| P/TBV Ratio | 2.37 | 2.73 | 2.74 | 3.77 | 4.19 | - | Upgrade
|
| P/FCF Ratio | - | - | - | 47.56 | 87.71 | - | Upgrade
|
| P/OCF Ratio | 78.60 | 63.73 | 45.70 | 33.16 | 72.80 | - | Upgrade
|
| EV/Sales Ratio | 8.40 | 10.12 | 6.66 | 12.48 | 15.93 | - | Upgrade
|
| EV/EBITDA Ratio | 139.04 | 84.03 | 26.66 | 67.14 | 62.68 | - | Upgrade
|
| EV/EBIT Ratio | - | 152.20 | 30.37 | 85.29 | 72.96 | - | Upgrade
|
| EV/FCF Ratio | -167.47 | - | - | 36.76 | 83.70 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.12 | 0.09 | 0.04 | 0.08 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.04 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.69 | -0.71 | -0.77 | -0.86 | -0.84 | -0.49 | Upgrade
|
| Net Debt / EBITDA Ratio | -63.60 | -30.39 | -10.97 | -20.42 | -13.53 | -1.58 | Upgrade
|
| Net Debt / FCF Ratio | 72.52 | 23.87 | 36.73 | -11.18 | -18.07 | -3.19 | Upgrade
|
| Asset Turnover | 0.18 | 0.18 | 0.26 | 0.21 | 0.35 | 0.77 | Upgrade
|
| Inventory Turnover | 2.44 | 2.04 | 2.76 | 3.62 | 3.20 | 2.86 | Upgrade
|
| Quick Ratio | 12.79 | 10.44 | 10.86 | 10.01 | 19.65 | 4.66 | Upgrade
|
| Current Ratio | 13.95 | 11.40 | 11.98 | 10.66 | 20.67 | 6.09 | Upgrade
|
| Return on Equity (ROE) | 1.66% | 3.92% | 7.60% | 5.59% | 8.32% | 28.28% | Upgrade
|
| Return on Assets (ROA) | -0.06% | 0.74% | 3.60% | 1.95% | 4.71% | 16.15% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.30% | 4.44% | 29.32% | 18.58% | 28.75% | 67.67% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.10% | 1.30% | 6.10% | 3.30% | 5.30% | 28.40% | Upgrade
|
| Earnings Yield | 0.73% | 1.49% | 2.81% | 1.51% | 1.35% | - | Upgrade
|
| FCF Yield | -0.42% | -1.12% | -0.79% | 2.10% | 1.14% | - | Upgrade
|
| Dividend Yield | 1.41% | 1.19% | 2.30% | 1.22% | 0.85% | - | Upgrade
|
| Payout Ratio | 190.38% | 151.00% | 54.51% | 57.24% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.56% | 0.91% | -0.97% | -33.19% | 1.01% | -0.90% | Upgrade
|
| Total Shareholder Return | 0.85% | 2.10% | 1.33% | -31.97% | 1.86% | -0.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.